Published by Josh White on 28th May 2021
(Sharecast News) - Commercial stage pharmaceutical company Shield Therapeutics announced on Friday that Greg Madison has been appointed as its chief executive officer, with effect from 1 June.
URL: http://www.digitallook.com/dl/news/story/31882069/...